ALMR Alamar Biosciences, Inc.
Nasdaq · SEC CIK 2104204 · EDGAR
- Bought, last 12 months
- $8.00M 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 11 since 2026-04-20, latest 2026-09-16 16:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Illumina Innovation Fund II GP, L.L.C. | 10% | $4.00M | — |
| Naclerio Nicholas | Dir | $4.00M | — |
| Chen Shiping | COO, Dir | — | — |
| Luo Yuling | CEO, Dir | — | — |
| White Timothy Ogden | Pres | — | — |
| Qiming Corporate GP VI, Ltd. | 10% | — | — |
| Brottem John L. | GC | — | — |
| McAnear Justin J. | CFO | — | — |
| RAGUSA ROBERT P | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-16 16:20 | 2026-09-14 | ALMR | Brottem John L. | GC | A - Grant | $0.00 | +29.0K | 29.0K | New | $0 |
| D | 2026-09-03 16:27 | 2026-09-01 | ALMR | RAGUSA ROBERT P | Dir | A - Grant | $0.00 | +5,686 | 5,686 | New | $0 |
| DMI | 2026-04-22 16:16 | 2026-04-20 | ALMR | Qiming Corporate GP VI, Ltd. | 10% | C - Cnv Deriv | — | +10.59M | 1.92M | New | — |
| DMI | 2026-04-22 16:16 | 2026-04-20 | ALMR | Qiming Corporate GP VI, Ltd. | 10% | J - Other | — | 0 | 1.92M | New | — |
| DMI | 2026-04-20 20:45 | 2026-04-20 | ALMR | Illumina Innovation Fund II GP, L.L.C. | 10% | C - Cnv Deriv | — | +6.13M | 271.8K | New | — |
| DMI | 2026-04-20 20:45 | 2026-04-20 | ALMR | Illumina Innovation Fund II GP, L.L.C. | 10% | J - Other | — | 0 | 5.51M | New | — |
| DI | 2026-04-20 20:45 | 2026-04-20 | ALMR | Illumina Innovation Fund II GP, L.L.C. | 10% | P - Purchase | $17.00 | +235.3K | 507.1K | +87% | +$4.00M |
| DM | 2026-04-20 20:35 | 2026-04-20 | ALMR | White Timothy Ogden | Pres | J - Other | — | 0 | 454.6K | New | — |
| D | 2026-04-20 20:35 | 2026-04-20 | ALMR | White Timothy Ogden | Pres | A - Grant | $0.00 | +37.2K | 491.8K | +8% | $0 |
| DM | 2026-04-20 20:34 | 2026-04-20 | ALMR | Chen Shiping | COO, Dir | C - Cnv Deriv | — | +393.4K | 722.9K | +119% | — |
| DM | 2026-04-20 20:34 | 2026-04-20 | ALMR | Chen Shiping | COO, Dir | J - Other | $0.00 | 0 | 722.9K | New | $0 |
| D | 2026-04-20 20:34 | 2026-04-20 | ALMR | Chen Shiping | COO, Dir | A - Grant | $0.00 | +37.2K | 760.1K | +5% | $0 |
| DM | 2026-04-20 20:33 | 2026-04-20 | ALMR | Luo Yuling | CEO, Dir | C - Cnv Deriv | — | +1.75M | 1.86M | +1,549% | — |
| DM | 2026-04-20 20:33 | 2026-04-20 | ALMR | Luo Yuling | CEO, Dir | J - Other | — | 0 | 1.86M | New | — |
| D | 2026-04-20 20:33 | 2026-04-20 | ALMR | Luo Yuling | CEO, Dir | A - Grant | $0.00 | +76.5K | 1.94M | +4% | $0 |
| DI | 2026-04-20 20:33 | 2026-04-20 | ALMR | Luo Yuling | CEO, Dir | C - Cnv Deriv | — | +1.22M | 1.22M | New | — |
| DMI | 2026-04-20 20:33 | 2026-04-20 | ALMR | Luo Yuling | CEO, Dir | J - Other | — | 0 | 1.22M | New | — |
| D | 2026-04-20 20:33 | 2026-04-20 | ALMR | McAnear Justin J. | CFO | A - Grant | $0.00 | +37.2K | 37.2K | New | $0 |
| DMI | 2026-04-20 20:31 | 2026-04-20 | ALMR | Naclerio Nicholas | Dir | C - Cnv Deriv | — | +6.13M | 271.8K | New | — |
| DMI | 2026-04-20 20:31 | 2026-04-20 | ALMR | Naclerio Nicholas | Dir | J - Other | — | 0 | 5.51M | New | — |
| DI | 2026-04-20 20:31 | 2026-04-20 | ALMR | Naclerio Nicholas | Dir | P - Purchase | $17.00 | +235.3K | 507.1K | +87% | +$4.00M |
| D | 2026-04-20 20:31 | 2026-04-20 | ALMR | Naclerio Nicholas | Dir | A - Grant | $0.00 | +5,686 | 5,686 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations